PerMedFH is a major EU-funded personalised medicine initiative focused on transforming the diagnosis and treatment of Familial Hypercholesterolaemia (FH), a common but underdiagnosed genetic condition. The project brings together researchers, clinicians, and patient organisations across Europe to develop tools for high-throughput variant classification, drug optimisation, and digital clinical support.
This is one of several interconnected research projects for which I’ve designed and developed websites including the earlier FH-EARLY and PERFECTO platforms ensuring visual and structural consistency across the family of sites while giving each its own unique identity.
The public-facing website was designed to be clean, visually engaging, and easy to navigate. Key sections highlight the project’s goals, work packages, partner organisations, and clinical relevance. Special attention was given to communicating how PerMedFH bridges the gap between cutting-edge research and real-world patient benefit.
Working closely with the consortium, I implemented a custom WordPress build integrating custom post types for News, Events, Glossary, and Project Partners. The design adheres to EU funding and branding guidelines, including the use of La Caixa Foundation branding, with a fully responsive and multilingual-ready structure.
Launched in 2025, the PerMedFH site now serves as the central communication hub for the project, supporting outreach to clinicians, researchers, and patient communities. It clearly articulates the long-term vision of integrating personalised FH care into clinical practice and lays the foundation for future modules, such as a clinician-facing web app and educational resources for affected families. Together with its sister sites, it contributes to a cohesive digital presence for this pan-European research effort.
